10TH Thermal and Fluids Engineering Conference (Hybrid) Partially online virtual and in person at George Washington University, Washington, DC, USA
Intense research effort in low-temperature (or cold) atmospheric plasma application in bioengineering led to foundation of a new field, plasma medicine. Cold atmospheric plasmas (CAP) produce chemically reactive species including reactive oxygen species (ROS) and reactive nitrogen species (RNS). These species are known to have biological effects on cells, such as the peroxidation of lipids and proteins. The most recent research area of plasma medicine is the interaction of CAP with cancer cells. It has been demonstrated by several investigators that CAP can induce apoptosis (programmed cell death) in various cancer cell lines. In addition, CAP treatment affects preferentially the cell cycle of cancer cells. This opened up the possibility that CAP could be the basis of a new cancer therapy. The uniqueness of low-temperature plasma is in its ability to change composition in situ. The above-mentioned biomedical applications seem to usher a new transformational approach to healthcare based on CAP technology. Recent efforts culminated in a successful clinical trial. In this presentation a review of the research achievements accomplished in the last decade and translational potential of this technology will be presented.
1940 0